Core Viewpoint - The law firm Kirby McInerney LLP is reminding investors of Klarna Group plc about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's IPO and subsequent financial disclosures [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that Klarna's Registration Statement during its September 2025 IPO contained false or misleading statements and failed to disclose the risk of a significant increase in loss reserves shortly after the IPO [3]. - Klarna launched its IPO on September 2025, selling 34,311,274 shares at a price of $40.00 per share [4]. - Following the announcement of disappointing Q3 2025 financial results on November 18, 2025, which revealed a substantial increase in credit loss provisions, Klarna's share price fell by $3.25, or approximately 9.3%, from $34.88 to $31.63 [4]. Group 2: Legal Process and Contact Information - The lead plaintiff in a class action lawsuit oversees the litigation and can influence key decisions, including litigation strategy and settlement [2]. - Investors who purchased Klarna securities and wish to learn more about the investigation can contact Lauren Molinaro of Kirby McInerney LLP for further information [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Aquestive Therapeutics, Inc. (Beta Bionics) due to significant stock losses following a disappointing earnings announcement [2][5]. Group 1: Company Overview - Aquestive Therapeutics, Inc. is also referred to as Beta Bionics and is listed on NASDAQ under the ticker BBNX [2]. - The company experienced a significant decline in its stock price, with shares plunging approximately 37% on January 9, 2026, after announcing expectations of fewer patient starts in the fourth quarter than analysts had estimated [5]. Group 2: Legal Investigation - The investigation by Faruqi & Faruqi focuses on whether Beta Bionics issued misleading statements or failed to disclose important information that could affect investors [5]. - Investors who suffered significant losses in Beta Bionics stock or options are encouraged to contact the law firm to discuss their legal rights [1].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works, Inc. due to allegations of misleading statements and failure to disclose critical information regarding the company's financial performance and business strategy [2][5]. Financial Performance - Bath & Body Works reported a 1% year-over-year decline in revenue for Q3 2025, missing prior guidance of 1-3% growth [6]. - The company's net income dropped by 26% to $77 million [6]. - The full-year earnings per diluted share outlook was sharply reduced from a range of $3.28 to $3.53 to "at least $2.83" [6]. Business Strategy - The company's strategy of pursuing "adjacencies, collaborations and promotions" was found to be ineffective in growing the customer base and delivering the expected growth in net sales [5]. - Bath & Body Works admitted that this strategy led to reduced investment in core categories and an overreliance on brand collaborations and promotions to mask weak financial results [6]. Stock Market Reaction - Following the disappointing financial disclosures, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [7].

Group 1 - Venu Holding Corporation conducted its initial public offering on November 27, 2024, issuing 1.2 million shares at a price of $10.00 per share [1] - On November 14, 2025, Venu reported third-quarter financial results, revealing revenue of $5.38 million, which was a 1.3% year-over-year decline and missed consensus estimates by $2.05 million [1] - Following the financial report, Venu's share price dropped by $2.37, or approximately 21.45%, from $11.05 on November 14, 2025, to close at $8.68 on November 17, 2025 [1] Group 2 - Kirby McInerney LLP is investigating potential violations of federal securities laws by Venu and its senior management [1] - No lawsuit has been filed yet, and the investigation aims to determine if claims can be brought under federal securities laws [2] - The law firm specializes in securities litigation and has achieved recoveries totaling billions of dollars for shareholders [3]

Core Viewpoint - A federal securities class action has been filed against Endeavor Group Holdings, Inc. for allegedly misleading statements made during the Class Period from January 15, 2025, to March 24, 2025, affecting investors who sold their shares during this time [1][2]. Group 1: Allegations Against Endeavor - The Complaint claims that Endeavor's Defendants made materially false and misleading statements regarding the fairness of the take-private merger and the $27.50-per-share Merger Consideration for public shareholders [2]. - It is alleged that the Defendants, led by Silver Lake and Endeavor insiders, conspired to undermine minority shareholders' bargaining power and the value they could realize, while insiders benefited from future gains through rollovers and other advantages [2]. - The structure of the Merger is said to have disadvantaged minority shareholders by rejecting a "majority-of-the-minority" vote and finalizing the transaction through controller written consent, locking in a fixed cash-out Merger Consideration without any contingencies [6]. Group 2: Legal Proceedings - Investors wishing to be appointed as Lead Plaintiff must file a motion with the court by March 18, 2026 [3]. - Wolf Haldenstein Adler Freeman & Herz LLP, the law firm handling the case, emphasizes its long-standing commitment to justice for investors harmed by misrepresented statements, backed by over 125 years of experience in securities litigation [3].

Core Points - A class action lawsuit has been filed against CoreWeave, Inc. in the United States District Court for the District of New Jersey on behalf of investors who purchased CoreWeave securities between March 28, 2025, and December 15, 2025 [2] - The lawsuit alleges that CoreWeave's management issued false and misleading statements regarding the company's ability to meet customer demand and understated risks associated with reliance on a single third-party data center supplier [3] Allegation Details - The allegations include that CoreWeave overstated its capability to meet customer demand for its services [3] - It is claimed that the company materially understated the risks posed by its reliance on a single third-party data center supplier, which could negatively impact revenue [3] Next Steps - Investors who suffered losses and wish to learn more about the claims or have questions can contact the law firm Bragar Eagel & Squire, P.C. for further information [4]

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for allegedly making materially false and misleading statements regarding the company's Long Island City property and its leasing value as a life-science destination during the specified Class Period from January 27, 2025, to October 27, 2025 [3][7]. Allegation Details - The lawsuit claims that the defendants provided overwhelmingly positive statements while concealing adverse facts about the true state of the Long Island City property [3]. - It is alleged that the company's claims regarding the leasing value of the LIC property were misleading and lacked a reasonable basis, particularly concerning the Megacampus™ strategy [3]. - As a result, the defendants' statements about the company's business, operations, and prospects were materially false and misleading throughout the Class Period [3]. Next Steps - Investors who purchased or acquired Alexandria shares and suffered losses are encouraged to contact the law firm for more information about their rights and potential claims [4][7]. - There is no cost or obligation for investors to inquire about their legal options [4]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial litigation [5]. - The firm operates nationwide and handles cases in both federal and state courts [5].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into ZoomInfo Technologies, Inc. following significant financial challenges and a securities class action lawsuit against the company and its executives [1][3]. Financial Performance - In Q2 2024, ZoomInfo reported a $33 million charge due to non-payments from customers, prompting the implementation of a new business risk model to mitigate write-offs [2]. - The company revised its annual revenue guidance downward by $65 million, adjusting the range from $1.255 billion to $1.27 billion to a new range of $1.19 billion to $1.205 billion [2]. Legal Issues - ZoomInfo and certain executives are facing a securities class action lawsuit for allegedly failing to disclose material information, violating federal securities laws [3]. - A court has denied the company's motion to dismiss part of the lawsuit, allowing the case to proceed [3]. Investigation Details - Kahn Swick & Foti's investigation is focused on potential breaches of fiduciary duties by ZoomInfo's officers and/or directors, as well as possible violations of state or federal laws [3].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into Vestis Corporation following significant financial disclosures and a related securities class action lawsuit against the company and its executives [1][2][3]. Financial Performance - In May 2025, Vestis Corporation announced its 2Q 2025 financial results, retracting its revenue and growth guidance for the full fiscal year 2025, citing "lost business in excess of new business" and "lower adds over stops" as primary reasons for the disappointing outlook [2]. Legal Issues - The company and certain executives are facing a securities class action lawsuit for allegedly failing to disclose material information, which is currently ongoing [2]. - KSF's investigation is focused on whether Vestis' officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [3]. Company Background - Kahn Swick & Foti, LLC is recognized as a leading boutique securities litigation law firm, with a strong track record in recovering investment losses due to corporate fraud or malfeasance [4].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into Fortrea Holdings, Inc. following disappointing financial results and ongoing legal issues related to securities class action lawsuits [1][2][3]. Company Overview - Fortrea Holdings, Inc. was spun off from Labcorp Holdings Inc. in June 2023, becoming a standalone publicly traded company [2]. - The company entered into transition services agreements with Labcorp, agreeing to pay for certain transitional services over a specified period [2]. Financial Performance - On March 3, 2025, Fortrea announced disappointing Q4 and full year 2024 financial results, missing previously announced guidance for revenue and adjusted EBITDA [2]. - The company indicated that pre-spin projects are generating less revenue and profitability than expected for 2025, and post-spin work is not progressing quickly enough to offset the pre-spin contract economics [2]. Legal Issues - Following the financial disclosures, Fortrea and certain executives were sued in a securities class action lawsuit for failing to disclose material information, which is still ongoing [2][3]. - KSF's investigation is focused on potential breaches of fiduciary duties by Fortrea's officers and/or directors, as well as possible violations of state or federal laws [3].